REDHILL BIOPHARMA LTD. (RDHL) Free cash flow 2015–2024
REDHILL BIOPHARMA LTD. (RDHL) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$9.4MFY2024 · since FY2015: -$17.8M → -$9.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$9.4M | +73.8% |
| FY2023 | -$35.8M | -21.9% |
| FY2022 | -$29.4M | +54.9% |
| FY2021 | -$65.2M | -33.0% |
| FY2020 | -$49.0M | -19.7% |
| FY2019 | -$40.9M | -18.7% |
| FY2018 | -$34.5M | +23.2% |
| FY2017 | -$44.9M | -58.5% |
| FY2016 | -$28.3M | -58.9% |
| FY2015 | -$17.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More RDHL financial trends
RDHL RevenueRDHL Net incomeRDHL Net marginRDHL Gross profitRDHL Gross marginRDHL Operating incomeRDHL Operating marginRDHL Operating cash flowRDHL Capital expendituresRDHL Return on equityRDHL Stock buybacksRDHL Dividends paidRDHL Total assetsRDHL Total liabilitiesRDHL Shareholders’ equityRDHL overview →